Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Abbvie Inc shares valued at $8,407,055 were sold by SALEKI-GERHARDT AZITA on Aug 12 ’25. At $198.42 per share, SALEKI-GERHARDT AZITA sold 42,370 shares. The insider’s holdings dropped to 177,292 shares worth approximately $37.08 million following the completion of this transaction.
Also, AZITA SALEKI-GERHARDT purchased 42,370 shares, netting a total of over 8,407,068 in proceeds.
Before that, Richard A. Gonzalez had added 61,500 shares to its account. In a trade valued at $12,043,268, the Former Director bought Abbvie Inc shares for $195.83 each.
Analysts at Daiwa Securities upgraded the stock from ‘”a Neutral”‘ to ‘”an Outperform”‘ outlook in a report released in early August. As of May 14, 2025, Citigroup has decreased its “Buy” rating to a “Neutral” for ABBV. Earlier on April 22, 2025, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for ABBV stock.
Analyzing ABBV Stock Performance
On last trading session, Abbvie Inc [NYSE: ABBV] rose 1.44% to $209.15. The stock’s lowest price that day was $206.65, but it reached a high of $211.6938 in the same session. During the last five days, there has been a surge of approximately 3.81%. Over the course of the year, Abbvie Inc shares have jumped approximately 7.86%. Shares of the company reached a 52-week high of $218.66 on 03/10/25 and a 52-week low of $164.39 on 04/09/25.
Support And Resistance Levels for Abbvie Inc (ABBV)
According to the 24-hour chart, there is a support level at 206.64, which, if violated, would cause prices to drop to 204.12. In the upper region, resistance lies at 211.68. The next price resistance is at 214.21. RSI (Relative Strength Index) is 73.37 on the 14-day chart, showing overbought technical sentiment.
Is Abbvie Inc subject to short interest?
Stocks of Abbvie Inc saw a sharp steep in short interest on 2025-07-31 dropping by -0.83 million shares to 15.13 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 15.95 million shares. A decline of -5.46% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.68 of the overall float, the days-to-cover ratio (short ratio) decline to 2.68.
Which companies own the most shares of Abbvie Inc (ABBV)?
In terms of Abbvie Inc share price expectations, FactSet research, analysts set an average price target of 172 in the next 12 months, down nearly -16.58% from the previous closing price of $206.19. Analysts anticipate Abbvie Inc stock to reach 226 by 2025, with the lowest price target being 127. In spite of this, 27 analysts ranked Abbvie Inc stock as Buy at the end of 2025. On December 10, 2024, BofA Securities assigned a price target of “a Neutral” to the stock and resumed coverage with a $191.
